These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22872208)

  • 1. Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports.
    Isaac CR; Chalita MR; Pinto LD
    Arq Bras Oftalmol; 2012; 75(3):213-4. PubMed ID: 22872208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: "Botulinum toxin type A as a migraine preventive treatment" (Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX Migraine Clinical Research Group. Headache. 2000;40:445-450).
    Galvez-Jimenez N; Hanson MR
    Headache; 2001 Jun; 41(6):607. PubMed ID: 11437903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
    Sheen-Ophir S; Almog Y
    Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation.
    Aristodemou P; Watt L; Baldwin C; Hugkulstone C
    Ophthalmic Plast Reconstr Surg; 2006; 22(2):134-6. PubMed ID: 16550061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diplopia following subcutaneous injections of botulinum A toxin for facial spasms.
    Wutthiphan S; Kowal L; O'Day J; Jones S; Price J
    J Pediatr Ophthalmol Strabismus; 1997; 34(4):229-34. PubMed ID: 9253737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin to the lateral rectus for the treatment of esotropia with paradoxical diplopia.
    Harris G; Dawson E; Lee J
    Strabismus; 2001 Jun; 9(2):79-82. PubMed ID: 11458296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of botulinum toxin A in treatment of intractable diplopia.
    Özkan SB; Akyüz Ünsal Aİ
    J AAPOS; 2017 Oct; 21(5):354-356.e2. PubMed ID: 28888968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double vision due to lateral rectus injury after cosmetic botulinum toxin injections.
    Khan S; Pathak G; Milgraum D; Tamhankar M; Milgraum S
    Australas J Dermatol; 2023 Aug; 64(3):e220-e223. PubMed ID: 37386928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of botulinum toxin A in diplopia following orbital decompression.
    Wutthiphan S
    Strabismus; 2008; 16(3):112-5. PubMed ID: 18788059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and efficacy of botulinum toxin in hemifacial spasm].
    Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
    J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral superior oblique palsy: etiology and therapeutic options.
    Merino PS; Rojas PL; Gómez De Liaño PS; Fukumitsu HM; Yáñez JM
    Eur J Ophthalmol; 2014; 24(2):147-52. PubMed ID: 24030536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin.
    Carruthers A; Carruthers J
    Dermatol Surg; 1998 Nov; 24(11):1189-94. PubMed ID: 9834738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin as an initial therapy for management of sixth nerve palsies caused by nasopharyngeal carcinomas.
    Wong ES; Lam CPS; Lau FHS; Lau WWY; Yam JCS
    Eye (Lond); 2018 Apr; 32(4):768-774. PubMed ID: 29386618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporary management of diplopia with botulinum toxin in multiple ocular motor cranial neuropathies.
    Tejedor J; Díez L
    Eur J Ophthalmol; 2012; 22(6):1042-4. PubMed ID: 23097020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of botulinum toxin in consecutive and secondary exotropia: outcome in patients initially treated with botulinum toxin.
    Lawson JM; Kousoulides L; Lee JP
    J AAPOS; 1998 Aug; 2(4):195-200. PubMed ID: 10532736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.
    Bottet F; Peyronnet B; Boissier R; Reiss B; Previnaire JG; Manunta A; Kerdraon J; Ruffion A; Lenormand L; Perrouin Verbe B; Gaillet S; Gamé X; Karsenty G;
    Neurourol Urodyn; 2018 Jan; 37(1):291-297. PubMed ID: 28431196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A (BOTOX) for treatment of migraine.
    Binder WJ; Brin MF; Blitzer A; Pogoda JM
    Dis Mon; 2002 May; 48(5):323-35. PubMed ID: 12195263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection for postoperative diplopia testing in adult strabismus.
    Khan J; Kumar I; Marsh IB
    J AAPOS; 2008 Feb; 12(1):46-8. PubMed ID: 17964210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of periocular depigmentation after repeated botulinum toxin A injections in African American patients.
    Roehm PC; Perry JD; Girkin CA; Miller NR
    J Neuroophthalmol; 1999 Mar; 19(1):7-9. PubMed ID: 10098540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.